查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617142

2030 年大麻二酚市场预测：按产品类型、来源、分销管道、给药途径、应用、最终用户和地区进行的全球分析

Cannabidiol Market Forecasts to 2030 - Global Analysis By Product Type, Source, Distribution Channel, Route of Administration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球大麻二酚市场规模为 76 亿美元，预计预测期内复合年增长率为 19.1%，到 2030 年将达到 218 亿美元。

大麻二酚 (CBD) 是大麻植物（尤其是大麻）中发现的天然化合物。与具有精神作用的 THC 不同，CBD 不会让你「兴奋」。 CBD 因其潜在的治疗特性（例如减轻焦虑、疼痛和发炎）而受到广泛关注。 CBD 通常用于油、胶囊、食品和外用产品。由于大麻的法律地位不同，其使用和监管因国家而异，但研究仍在探索其对各种健康状况的有效性。

根据国际设施管理协会（IMFA）的数据，2020年84%的店内业务受到疫情影响，其中食品服务占最大份额。

合法化和更广泛的接受

大麻二酚（CBD）的合法化和接受度在世界各地不断增加，市场正在迅速扩大。随着越来越多的国家和州接受 CBD 的潜在治疗功效，消费者的需求也在增长。 CBD 现在广泛应用于健康产品、护肤，甚至食品和饮料中。这种转变，加上支持 CBD 安全和健康益处的科学研究，以及对其非精神活性特性的日益认识，正在推动行业更大的成长和创新。

缺乏标准化测试和品管

市场上缺乏标准化测试和品管给消费者带来了重大风险。如果没有一致的测试，产品功效、纯度和安全性可能会有很大差异，导致不可靠的体验和潜在的健康风险。农药和重金属等有害物质的污染也是一个问题。缺乏监管会损害消费者的信任，使品牌因产品品质不稳定而难以建立信任，并阻碍产业发展。

消费者对天然和有机产品的兴趣日益浓厚

消费者对天然和有机产品日益增长的兴趣正在对市场产生重大影响。随着越来越多的人寻求与整体、永续生活方式一致的健康解决方案，有机大麻衍生的 CBD 产品越来越受欢迎。消费者优先考虑透明度、品质和生态友善性，这推动了对有机 CBD 油、食品和护肤的需求。这种向天然替代品的转变，强调纯度、健康益处和道德采购，正在推动市场成长。

误解和偏见

对大麻二酚的误解和污名阻碍了其广泛的市场接受。儘管CBD无毒，但它经常被误认为是大麻的精神作用，导致潜在消费者感到困惑和不愿意。这种耻辱加上错误讯息，可能会阻碍人们探索 CBD 的治疗功效。此外，律师有时对于制定明确的指导方针犹豫不决，这阻碍了监管的进展。

COVID-19 的影响：

COVID-19 大流行对市场产生了各种影响。由于消费者寻求增强免疫力和缓解压力，对健康产品的需求激增，而供应链中断和商店关闭阻碍了产品的供应。此外，经济不确定性导致一些消费者优先考虑必需品，影响了 CBD 的销售。然而，疫情期间电子商务的兴起和心理健康意识的提高最终促进了市场的长期成长。

大麻衍生性商品预计将在预测期内成为最大的细分市场

由于消费者对天然健康产品的需求不断增加，预计大麻衍生领域将在预测期内占据最大的市场占有率。大麻衍生的 CBD 以其潜在的健康益处而闻名，并用于多种应用，包括护肤、营养食品和疼痛管理。它在许多地区的合法化以及对其治疗特性的认识不断提高，正在推动市场扩张。因此，大麻衍生的 CBD 市场继续吸引大量投资和创新。

预计医疗产业在预测期内复合年增长率最高

在外推期间，医疗保健产业预计将经历最高的复合年增长率。 CBD 越来越被认为可以有效治疗慢性疼痛、癫痫、焦虑和失眠等疾病。随着越来越多的国家将 CBD 的医疗用途合法化，并且正在进行的临床试验支持其益处，市场有望实现显着成长。随着消费者寻求替代疗法，对油、胶囊和酊剂等医用 CBD 产品的需求持续增长。

比最大的地区

由于消费者对天然保健产品的需求不断增长，预计北美地区在预测期内将占据最大的市场占有率。在美国和加拿大，围绕 CBD 的法律体制已经发展，许多州和省将基于大麻的产品用于医疗和娱乐用途合法化。该市场也受到不断增长的健康和自然疗法趋势的支持，这些趋势吸引了广泛的消费者并推动了对 CBD 产品的强劲需求。

复合年增长率最高的地区：

在健康趋势、监管变化和技术进步的推动下，亚太地区预计将在预测期内实现最高的成长率。精神和神经系统疾病的盛行率正在增加，增加了对 CBD 作为治疗选择的需求。电子商务平台的兴起使 CBD 企业能够直接接触消费者，从而在实体零售基础设施完全到位之前更容易进入市场。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球大麻二酚市场：依产品类型

  • 大麻二酚油
  • 大麻二酚胶囊和软胶囊
  • 食用大麻二酚
  • 大麻二酚外用药物
  • 大麻二酚化妆品
  • 其他产品类型

第六章 全球大麻二酚市场：依来源分类

  • 源自大麻
  • 大麻衍生

第七章全球大麻二酚市场：依分销管道

  • 网路零售
  • 专卖店
  • 超级市场和大卖场
  • 药局/药局

第八章全球大麻二酚市场：依给药途径

  • 口服
  • 局部的
  • 经皮吸收贴片
  • 吸入

第九章全球大麻二酚市场：依应用分类

  • 健康与保健
  • 医疗保健
  • 化妆品/个人护理
  • 食品/饮料
  • 其他用途

第 10 章 全球大麻二酚市场：依最终使用者分类

  • 成人
  • 老年人口
  • 宠物
  • 运动员和健身爱好者
  • 其他最终用户

第十一章全球大麻二酚市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章 公司概况

  • Medical Marijuana, Inc.
  • High Tide, Inc.
  • Curaleaf Holdings
  • Trulieve Cannabis Corp.
  • Canopy Growth Corporation
  • Tilray Brands
  • Aurora Cannabis Inc.
  • Charlotte's Web Holdings, Inc.
  • GW Pharmaceuticals plc
  • Lazarus Naturals
  • Select CBD
  • Veritas Farms
  • HempFusion
  • CBDistillery
  • Plus Products
Product Code: SMRC28020

According to Stratistics MRC, the Global Cannabidiol Market is accounted for $7.6 billion in 2024 and is expected to reach $21.8 billion by 2030 growing at a CAGR of 19.1% during the forecast period. Cannabidiol (CBD) is a natural compound found in the cannabis plant, specifically in hemp. Unlike its psychoactive counterpart, THC, CBD does not produce a "high." It has gained significant attention for its potential therapeutic properties, such as reducing anxiety, pain, and inflammation. CBD is commonly used in oils, capsules, edibles, and topical products. Research is ongoing to explore its effectiveness for various health conditions, though its use and regulation vary by country due to differing legal statuses of cannabis.

According to the International Facility Management Association (IMFA), 84% of in-store operations were affected due to the pandemic, of which food services represented a significant share in 2020.

Market Dynamics:

Driver:

Increasing legalization and acceptance

The increasing legalization and acceptance of cannabidiol (CBD) across the globe is rapidly expanding its market. As more countries and states embrace CBD for its potential therapeutic benefits, consumer demand grows. CBD is now widely used in wellness products, skincare, and even food and beverages. This shift is driven by growing awareness of its non-psychoactive properties, coupled with scientific research supporting its safety and health benefits, fostering greater industry growth and innovation.

Restraint:

Lack of standardized testing and quality control

The lack of standardized testing and quality control in the market poses significant risks to consumers. Without consistent testing, products may vary widely in potency, purity, and safety, leading to unreliable experiences and potential health risks. Contamination with harmful substances, such as pesticides or heavy metals, is also a concern. This lack of regulation undermines consumer trust and hampers the growth of the industry, as inconsistent product quality makes it difficult for brands to build credibility.

Opportunity:

Growing consumer interest in natural and organic products

The growing consumer interest in natural and organic products has significantly influenced the market. As more people seek wellness solutions that align with holistic and sustainable lifestyles, CBD products derived from organic hemp are becoming increasingly popular. Consumers are prioritizing transparency, quality, and eco-friendly practices, driving demand for organic CBD oils, edibles, and skincare. This shift towards natural alternatives is fueling market growth, with an emphasis on purity, health benefits, and ethical sourcing.

Threat:

Misconceptions and stigma

Misconceptions and stigma surrounding cannabidiol continue to hinder its widespread acceptance in the market. Despite its non-intoxicating nature, CBD is often mistakenly associated with marijuana's psychoactive effects, causing confusion and reluctance among potential consumers. This stigma, coupled with misinformation, can discourage people from exploring its therapeutic benefits. Additionally, it impedes regulatory progress, as lawmakers may hesitate to establish clear guidelines.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While demand for wellness products surged as consumers sought immunity-boosting and stress-relief solutions, supply chain disruptions and store closures hindered product availability. Additionally, economic uncertainty led some consumers to prioritize essential goods, affecting CBD sales. However, the rise of e-commerce and increased awareness of mental health during the pandemic ultimately contributed to long-term market growth.

The hemp-derived segment is expected to be the largest during the forecast period

The hemp-derived segment is expected to account for the largest market share during the projection period due to increasing consumer demand for natural wellness products. Hemp-derived CBD, known for its potential health benefits, is used in various applications such as skincare, dietary supplements, and pain management. Legalization in many regions, along with growing awareness about its therapeutic properties, has fueled market expansion. As a result, the hemp-derived CBD market continues to attract significant investment and innovation.

The medical segment is expected to have the highest CAGR during the forecast period

The medical segment is expected to have the highest CAGR during the extrapolated period. CBD is increasingly recognized for its effectiveness in treating conditions like chronic pain, epilepsy, anxiety, and insomnia. With more countries legalizing medical CBD and ongoing clinical trials supporting its benefits, the market is poised for significant growth. The demand for medical-grade CBD products, including oils, capsules, and tinctures, continues to rise among consumers seeking alternative treatments.

Region with largest share:

North America region is estimated to account for the largest market share during the forecast period driven by increasing consumer demand for natural wellness products. In the U.S. and Canada, the legal framework surrounding CBD has evolved, with many states and provinces legalizing cannabis-based products for medical and recreational use. The market is also supported by the growing trend of wellness and natural remedies, attracting a wide consumer base and fueling strong demand for CBD-infused products.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by health trends, regulatory changes, and technological advancements. There is a rising prevalence of mental disorders and neurological diseases, which is increasing the demand for CBD as a therapeutic option. The rise of e-commerce platforms allows CBD companies to reach consumers directly, facilitating market entry before physical retail infrastructures are fully developed.

Key players in the market

Some of the key players in Cannabidiol Market include Medical Marijuana, Inc., High Tide, Inc., Curaleaf Holdings, Trulieve Cannabis Corp., Canopy Growth Corporation, Tilray Brands, Aurora Cannabis Inc., Charlotte's Web Holdings, Inc., GW Pharmaceuticals plc, Lazarus Naturals, Select CBD, Veritas Farms, HempFusion, CBDistillery and Plus Products.

Key Developments:

In January 2024, Aurora Cannabis Inc., an American cannabis-based products manufacturing company, launched cannabis-infused ready-to-drink product produced by Vacay and Versus. The newly launched products are available in three different fruit flavors - Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz.

In January 2023, Medical Marijuana, Inc.'s subsidiary HempMedsBrasil introduced two new full-spectrum cannabidiol products in Brazil, available in concentrations ranging from 3,000-6,000 mg and sizes of 30 mL and 60 mL.

Product Types Covered:

  • Cannabidiol Oil
  • Cannabidiol Capsules and Softgels
  • Cannabidiol Edibles
  • Cannabidiol Topicals
  • Cannabidiol Cosmetics
  • Other Product Types

Sources Covered:

  • Hemp-Derived
  • Marijuana-Derived

Distribution Channels Covered:

  • Online Retail
  • Specialty Stores
  • Supermarkets & Hypermarkets
  • Pharmacies & Drug Stores

Route of Administrations Covered:

  • Oral
  • Topical
  • Transdermal Patches
  • Inhalation

Applications Covered:

  • Health & Wellness
  • Medical
  • Cosmetics & Personal Care
  • Food & Beverages
  • Other Applications

End Users Covered:

  • Adults
  • Elderly Population
  • Pets
  • Athletes & Fitness Enthusiasts
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cannabidiol Market, By Product Type

  • 5.1 Introduction
  • 5.2 Cannabidiol Oil
  • 5.3 Cannabidiol Capsules and Softgels
  • 5.4 Cannabidiol Edibles
  • 5.5 Cannabidiol Topicals
  • 5.6 Cannabidiol Cosmetics
  • 5.7 Other Product Types

6 Global Cannabidiol Market, By Source

  • 6.1 Introduction
  • 6.2 Hemp-Derived
  • 6.3 Marijuana-Derived

7 Global Cannabidiol Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Retail
  • 7.3 Specialty Stores
  • 7.4 Supermarkets & Hypermarkets
  • 7.5 Pharmacies & Drug Stores

8 Global Cannabidiol Market, By Route of Administration

  • 8.1 Introduction
  • 8.2 Oral
  • 8.3 Topical
  • 8.4 Transdermal Patches
  • 8.5 Inhalation

9 Global Cannabidiol Market, By Application

  • 9.1 Introduction
  • 9.2 Health & Wellness
  • 9.3 Medical
  • 9.4 Cosmetics & Personal Care
  • 9.5 Food & Beverages
  • 9.6 Other Applications

10 Global Cannabidiol Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Elderly Population
  • 10.4 Pets
  • 10.5 Athletes & Fitness Enthusiasts
  • 10.6 Other End Users

11 Global Cannabidiol Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medical Marijuana, Inc.
  • 13.2 High Tide, Inc.
  • 13.3 Curaleaf Holdings
  • 13.4 Trulieve Cannabis Corp.
  • 13.5 Canopy Growth Corporation
  • 13.6 Tilray Brands
  • 13.7 Aurora Cannabis Inc.
  • 13.8 Charlotte's Web Holdings, Inc.
  • 13.9 GW Pharmaceuticals plc
  • 13.10 Lazarus Naturals
  • 13.11 Select CBD
  • 13.12 Veritas Farms
  • 13.13 HempFusion
  • 13.14 CBDistillery
  • 13.15 Plus Products

List of Tables

  • Table 1 Global Cannabidiol Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Cannabidiol Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Cannabidiol Market Outlook, By Cannabidiol Oil (2022-2030) ($MN)
  • Table 4 Global Cannabidiol Market Outlook, By Cannabidiol Capsules and Softgels (2022-2030) ($MN)
  • Table 5 Global Cannabidiol Market Outlook, By Cannabidiol Edibles (2022-2030) ($MN)
  • Table 6 Global Cannabidiol Market Outlook, By Cannabidiol Topicals (2022-2030) ($MN)
  • Table 7 Global Cannabidiol Market Outlook, By Cannabidiol Cosmetics (2022-2030) ($MN)
  • Table 8 Global Cannabidiol Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Cannabidiol Market Outlook, By Source (2022-2030) ($MN)
  • Table 10 Global Cannabidiol Market Outlook, By Hemp-Derived (2022-2030) ($MN)
  • Table 11 Global Cannabidiol Market Outlook, By Marijuana-Derived (2022-2030) ($MN)
  • Table 12 Global Cannabidiol Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 13 Global Cannabidiol Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 14 Global Cannabidiol Market Outlook, By Specialty Stores (2022-2030) ($MN)
  • Table 15 Global Cannabidiol Market Outlook, By Supermarkets & Hypermarkets (2022-2030) ($MN)
  • Table 16 Global Cannabidiol Market Outlook, By Pharmacies & Drug Stores (2022-2030) ($MN)
  • Table 17 Global Cannabidiol Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 18 Global Cannabidiol Market Outlook, By Oral (2022-2030) ($MN)
  • Table 19 Global Cannabidiol Market Outlook, By Topical (2022-2030) ($MN)
  • Table 20 Global Cannabidiol Market Outlook, By Transdermal Patches (2022-2030) ($MN)
  • Table 21 Global Cannabidiol Market Outlook, By Inhalation (2022-2030) ($MN)
  • Table 22 Global Cannabidiol Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Cannabidiol Market Outlook, By Health & Wellness (2022-2030) ($MN)
  • Table 24 Global Cannabidiol Market Outlook, By Medical (2022-2030) ($MN)
  • Table 25 Global Cannabidiol Market Outlook, By Cosmetics & Personal Care (2022-2030) ($MN)
  • Table 26 Global Cannabidiol Market Outlook, By Food & Beverages (2022-2030) ($MN)
  • Table 27 Global Cannabidiol Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 28 Global Cannabidiol Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Cannabidiol Market Outlook, By Adults (2022-2030) ($MN)
  • Table 30 Global Cannabidiol Market Outlook, By Elderly Population (2022-2030) ($MN)
  • Table 31 Global Cannabidiol Market Outlook, By Pets (2022-2030) ($MN)
  • Table 32 Global Cannabidiol Market Outlook, By Athletes & Fitness Enthusiasts (2022-2030) ($MN)
  • Table 33 Global Cannabidiol Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.